Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up

✍ Scribed by Lisa Rydén; Karin Jirström; Monica Haglund; Olle Stål; Mårten Fernö

• Publisher: Springer US
• Year: 2010
• Tongue: English
• Weight: 267 KB
• Volume: 120
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-010-0758-6